USPTO Examiner BAKKAR AYA ZIAD - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19098832APPARATUS AND TECHNIQUES FOR SURGICAL LASER DELIVERYApril 2025September 2025Allow510NoNo
18883177APPARATUS AND TECHNIQUES FOR SURGICAL LASER DELIVERYSeptember 2024December 2024Allow300NoNo
18407254LIGHT THERAPY DEVICEJanuary 2024July 2025Allow1820NoNo
18512342LED INFRARED IRRADIATORNovember 2023April 2024Allow510YesNo
18381944APPARATUS AND TECHNIQUES FOR SURGICAL LASER DELIVERYOctober 2023July 2024Allow911YesNo
18555270PATIENT MONITORING SYSTEMOctober 2023February 2026Allow2810NoNo
18474707METHOD FOR PROVIDING CONTROL DATA FOR PRESBYOPIA REVERSION FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUSSeptember 2023March 2026Abandon2910NoNo
18371067WEARABLE BLOOD ANALYTE MEASUREMENT DEVICE AND METHOD FOR MEASURING BLOOD ANALYTE CONCENTRATIONSeptember 2023February 2025Allow1730YesNo
17918891MERIDIAN STIMULATION DEVICESeptember 2023November 2023Allow1300YesNo
18462278SYSTEM AND METHOD FOR TREATING OBSTRUCTIVE SLEEP APNEASeptember 2023June 2025Allow2210YesNo
18196259EYE-MOUNTABLE THERAPEUTIC DEVICES, AND ASSOCIATED SYSTEMS AND METHODSMay 2023June 2024Allow1310NoNo
18163165Inhibiting Viral Infection Using Alternating Electric FieldsFebruary 2023December 2023Allow1010NoNo
18150493GLUCOSE ESTIMATION WITHOUT CONTINUOUS GLUCOSE MONITORINGJanuary 2023January 2024Allow1220YesNo
18088404CHARACTERIZING AND IDENTIFYING BIOLOGICAL STRUCTUREDecember 2022August 2025Allow3221YesNo
18063533ENHANCING OPTICAL DETECTION OF MICRO BUBBLES BY LASER PULSE EXPANSIONDecember 2022October 2024Allow2210NoNo
17980735PHOTOTHERAPY DEVICE AND SYSTEMNovember 2022July 2025Abandon3210NoNo
18050886SEPARATE POSITIONABLE HEMOSTASIS VALVE FOR IMPLANTABLE MEDICAL LEAD INTRODUCER HUBOctober 2022March 2026Allow4010YesNo
17938587PERFORMING LASER VITREOLYSIS ON AN EYE WITH AN INTRAOCULAR LENSOctober 2022November 2025Allow3810YesNo
17995216EQUIPMENT AND METHODS FOR REFRACTIVE SURGERY, PARTICULARLY FOR KERATOPLASTYSeptember 2022January 2026Allow3920YesNo
17888524SYSTEM AND METHOD TO STIMULATE THE OPTIC NERVEAugust 2022February 2026Allow4240NoNo
17794120GARMENT ASSEMBLY FOR THE TRANSMISSION OF EXTERNAL LIGHTJuly 2022December 2024Allow2810NoNo
17854104ROBOTIC SURGICAL SYSTEM WITH REMOVABLE PORTION AND METHOD OF DISASSEMBLING SAMEJune 2022November 2025Allow4120YesNo
17789540WEARABLE DEVICE WITH SENSORS FOR HEALTH AND SAFETY MONITORINGJune 2022March 2025Abandon3210NoNo
17781589INDUCTIVE TRANSCUTANEOUS POWER DEVICE WITH OPEN-LOOP TEMPERATURE CONTROLJune 2022June 2025Abandon3610NoNo
17780433SUBJECT MONITORINGMay 2022February 2025Abandon3210NoNo
17745260ROBUST VENTRICULAR SENSING OF FAR-FIELD EGM OR ECG SIGNALS THAT AVOIDS OVERSENSING OF VENTRICULAR SENSED EVENTSMay 2022February 2025Allow3310YesNo
17775816LASER DEVICE FOR SKIN TREATMENTS AND METHODMay 2022February 2025Abandon3310NoNo
17739463TREATMENT CHAIRMay 2022March 2025Abandon3460YesNo
17773939SELF-SUFFICIENT CARDIAC PACEMAKERMay 2022August 2025Allow3910NoNo
17762943MEDICAL SYSTEM WITH CONNECTOR FORMING AN EXTERNAL WINDINGMarch 2022July 2025Allow4020YesNo
17698880SYSTEM AND METHOD OF ESTIMATING VITAL SIGNS OF USER USING ARTIFICIAL INTELLIGENCEMarch 2022September 2025Allow4230YesNo
17652578GROW LIGHT AND OCULAR LIGHT THERAPY ARRANGEMENTS AND METHODS FOR GROWING PLANTS AND FOR TREATING NEUROLOGICAL DISORDERSFebruary 2022September 2025Abandon4220YesNo
17585629Fiducial markerJanuary 2022September 2024Allow3210NoNo
17569321REDUCED SIZE FORCE SENSORJanuary 2022October 2024Abandon3310NoNo
17539055ELECTRONIC DEVICE, METHOD OF DETERMINING MENTAL STATE OF USER IN CONSIDERATION OF EXTERNAL MENTAL LEVEL ACCORDING TO INPUT BEHAVIOR OF USER, AND COMPUTER PROGRAMNovember 2021August 2024Abandon3310NoNo
17614758LED PATCH FOR SKIN CARE APPARATUS AND SKIN CARE APPARATUS INCLUDING THE SAMENovember 2021June 2024Allow3020NoNo
17523944LIGHT SUPPLY METHOD AND LIGHT SUPPLY SYSTEM FOR PHOTOTHERAPYNovember 2021October 2024Abandon3540NoNo
17506263INTEGRATED CHEMICAL/ULTRASONIC TRANSDUCER SENSOROctober 2021August 2025Allow4620YesNo
17505998HANDHELD MILLIMETER WAVE IRRADIATION DEVICEOctober 2021April 2024Abandon3030NoNo
17505320EXTENDABLE AND RETRACTABLE LEADOctober 2021October 2025Allow4821NoNo
17600753IMPROVED PHOTOTHERAPY SYSTEMOctober 2021May 2024Allow3210NoNo
17481293LIGHT THERAPY AS AN ADJUVANT TO CAROTID ENDARTERECTOMYSeptember 2021November 2024Allow3710YesNo
17474278SYSTEMS AND METHODS FOR PHOTOBIOMODULATIONSeptember 2021October 2024Abandon3710NoNo
17465656LIGHT THERAPY DEVICESeptember 2021August 2023Allow2410YesNo
17392399Theranostic laser systemAugust 2021February 2025Allow4240YesNo
17358757ANTI-MICROBIAL PHOTOBIOMODULATION SUBSTRATEJune 2021April 2024Abandon3410NoNo
17349244MACHINE LEARNING TECHNIQUES FOR GENERATING ICU PREDICTIONSJune 2021December 2024Abandon4220NoNo
17312970PHOTOBIOMODULATION (PBM) IN GENERAL LIGHTINGJune 2021August 2024Allow3920NoNo
17339991UV-Mask for Crosslinking Treatment of KeratoconusJune 2021January 2025Abandon4410NoNo
17299167Enhanced Authentication for IMD CommunicationJune 2021March 2025Abandon4530NoNo
17303318OCULAR LIGHT THERAPY ARRANGEMENT AND METHOD FOR TREATING NEUROLOGICAL DISORDERSMay 2021February 2024Allow3340YesNo
17328125IMPLANTABLE MEDICAL DEVICE WITH TEMPERATURE SENSORMay 2021July 2025Abandon5040NoNo
17295099SYSTEMS AND METHODS FOR CONTROLLING AGAINST ANEURYSM FORMATION, GROWTH AND RUPTURE, AND IMPROVING POST-RUPTURE OUTCOMESMay 2021January 2025Allow4421YesNo
17293957SYSTEM AND METHOD FOR INTERMITTENT ELECTRICAL MODULATIONMay 2021March 2025Allow4630YesNo
17292466SYSTEM AND METHOD FOR LOW COST LIGHT THERAPYMay 2021July 2025Abandon5040YesNo
17308669Sterilizing Mouthpiece AssemblyMay 2021September 2024Abandon4020NoNo
17239389HYBRID ELECTRO-PLASMONIC MODULATION OF NEURAL ACTIVITY WITH VISIBLE-LIGHT-SENSITIVE GOLD NANOTRANSDUCER INTERFACEApril 2021December 2023Allow3110NoNo
17285740LIGHT OUTPUTTING DEVICE FOR SCALP CAREApril 2021August 2024Allow4020NoNo
17277450LIGHT BASED DENTAL TREATMENT DEVICEMarch 2021January 2024Allow3410YesNo
17271961SYSTEM AND METHOD FOR NETWORK ANALYSIS OF A PATIENT'S NEURO CARDIO-RESPIRATORY-SYSTEMFebruary 2021May 2024Abandon3810NoNo
17176902CIRCADIAN OUTDOOR EQUIVALENCY METRIC FOR ASSESSING PHOTIC ENVIRONMENT AND HISTORYFebruary 2021January 2025Abandon4730NoNo
17264176BRAIN WAVE AND CELL ACTIVITY CONTROL DEVICE AND METHOD BASED ON LIGHT STIMULATION, AND DEVICE FOR IMPROVEMENT, PREVENTION, OR INCREASE IN BRAIN FUNCTIONJanuary 2021October 2025Abandon5660YesYes
17161401SURGICAL INSTRUMENTS AND SYSTEMS CONFIGURED TO DETECT, ANALYZE, AND/OR DISTINGUISH SMOKE AND STEAM DURING A SURGICAL PROCEDUREJanuary 2021November 2024Abandon4640YesNo
17150955DETERMINATION AND CORRELATION OF FLOW STATESJanuary 2021June 2024Abandon4110NoNo
17252094A DEVICE AND METHOD FOR VISUAL STIMULATIONDecember 2020June 2025Abandon5420NoNo
17115561SYSTEMS AND METHODS FOR ATRIAL FIBRILLATION BURDEN ESTIMATION, NOTIFICATION AND MANAGEMENT IN DAILY FREE-LIVING SCENARIOSDecember 2020October 2023Allow3420YesNo
17113864SYSTEM AND METHOD FOR DISPLAYING INFANT HEALTH INFORMATION IN CONNECTION WITH A NEONATAL WARMERDecember 2020September 2024Allow4531YesNo
17095900Blue Light PhotobiomodulationNovember 2020September 2024Allow4640YesNo
17094022MONITORING A PATIENT WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASENovember 2020January 2025Abandon5030YesNo
17094622DYNAMIC INTRAVASCULAR LITHOTRIPSY DEVICE WITH MOVABLE ENERGY GUIDENovember 2020August 2024Allow4541NoYes
17082331WEARABLE DISPLAY DEVICEOctober 2020February 2026Abandon6080NoNo
17025598HAIR TREATMENT SYSTEM WITH PROXIMITY SENSORS TO DETECT SCALP OR HAIR DISTANCE AND LOCALITYSeptember 2020December 2024Allow5170NoNo
17008181DETERMINATION AND ASSOCIATION OF TRUE FLOW STATESAugust 2020April 2024Abandon4301NoNo
17008191SYSTEMS AND METHODS FOR WIRELESSLY OBTAINING A PHYSIOLOGICAL SIGNAL FROM A PATIENTAugust 2020August 2025Allow6050YesNo
16969971ANNOTATION METHOD, ANNOTATION DEVICE, STORAGE MEDIUM, AND IDENTIFICATION SYSTEMAugust 2020June 2024Allow4611NoNo
16993052SYSTEMS AND METHODS FOR SUBJECT MONITORINGAugust 2020March 2026Abandon6060YesYes
16961793FULLY NON-INVASIVE BLOOD SUGAR LEVEL MONITORING APPARATUS INTEGRATED WITH REAL-TIME HEALTH SUPPORT SYSTEMJuly 2020July 2024Allow4912YesNo
16906243INFORMATION PROCESSING DEVICE, BIOLOGICAL INFORMATION MEASURING DEVICE, METHOD, AND NON-TRANSITORY RECORDING MEDIUM IN WHICH PROGRAM IS STOREDJune 2020September 2024Abandon5160YesNo
16888083CIRCADIAN RHYTHM MONITORING AND REGULATION SYSTEMMay 2020December 2024Allow5560YesNo
16842953EPIDERMAL PAPER-BASED ELECTRONIC DEVICESApril 2020April 2024Allow4830YesNo
16821024LIGHT IRRADIATION DEVICEMarch 2020January 2024Allow4670YesNo
16643078CARDIAC DEVICEFebruary 2020November 2022Allow3310YesNo
16482659METHOD AND APPARATUS FOR WEARABLE DEVICE WITH EEG AND BIOMETRIC SENSORSDecember 2019October 2025Allow6030YesNo
16691141ENERGY-DELIVERING ORTHODONTIC ALIGNER SYSTEMSNovember 2019July 2024Allow5560YesNo
16659807DATA PLAYBACK INTERFACE FOR A MEDICAL DEVICEOctober 2019November 2023Allow4860YesNo
16589191SYSTEMS AND METHODS FOR USING BREATH EVENTS IN SLEEP STAGINGOctober 2019June 2024Allow5650NoNo
16578140SYSTEM AND METHOD OF MODELING VASCULATURE IN NEAR REAL-TIMESeptember 2019September 2023Allow4830YesNo
16484712PROCESSING OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANSAugust 2019January 2024Allow5340YesYes
15975067MULTIPLEXED IMPLANTABLE SENSOR PROBEMay 2018July 2025Allow6090YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BAKKAR, AYA ZIAD.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
21.1%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
4
Allowed After Appeal Filing
2
(50.0%)
Not Allowed After Appeal Filing
2
(50.0%)
Filing Benefit Percentile
84.3%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BAKKAR, AYA ZIAD - Prosecution Strategy Guide

Executive Summary

Examiner BAKKAR, AYA ZIAD works in Art Unit 3796 and has examined 55 patent applications in our dataset. With an allowance rate of 60.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.

Allowance Patterns

Examiner BAKKAR, AYA ZIAD's allowance rate of 60.0% places them in the 20% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BAKKAR, AYA ZIAD receive 3.16 office actions before reaching final disposition. This places the examiner in the 89% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BAKKAR, AYA ZIAD is 46 months. This places the examiner in the 12% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +40.8% benefit to allowance rate for applications examined by BAKKAR, AYA ZIAD. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.2% of applications are subsequently allowed. This success rate is in the 19% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 8.6% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.